Equity-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement [Abstract]

A summary of stock options activity under the Plan as of March 31, 2023 and changes during three months ended March 31, 2023 is presented as follows:


	Shares	Weighted-Average Grant Date Fair Value per Share		Weighted-Average Exercise Price per Share		Weighted-Average Remaining Contractual Term (Years)











Outstanding at December 31, 2022	2,153,591	$	2.70	$	7.22	8.60


Forfeited	(37,999)	2.81		7.74
Outstanding at March 31, 2023	2,115,592	$	2.70	$	7.21	8.30

Schedule of Nonvested Restricted Stock Units Activity

A summary of restricted stock units activity under the Plan as of March 31, 2023 and changes during the three months ended March 31, 2023 is presented as follows:


	Restricted Shares	Weighted-Average Grant Date Fair Value per Share		Weighted-Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value








Unvested at December 31, 2022	2,282,778	$	6.30	1.3	$	4,520


Forfeited	(96,944)	7.19
Unvested at March 31, 2023	2,185,834	$	6.26	1.1	$	6,623

Schedule of Stock Compensation Expense

The table below presents the equity-based compensation expense recorded during the following periods:



	Three Months Ended
		March 31, 2023		March 31, 2022
Cost of Sales
Incentive Units		$	—	$	181
Stock Options		46		12
Restricted Stock Units		673		627
Total cost of sales		$	719	$	820

Selling, general and administrative expenses

Incentive Units		—		2,171
Stock Options		361		409
Restricted Stock Units		878		1,011
Total selling, general and administrative expenses		$	1,239	$	3,591

Total equity-based compensation expense		$	1,958	$	4,411